Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$513K Buy
1,458
+9
+0.6% +$3.21K 0.29% 61
2025
Q4
$474K Buy
1,449
+9
+0.6% +$2.85K 0.26% 64
2025
Q3
$406K Sell
1,440
-34
-2% -$9.86K 0.23% 68
2025
Q2
$412K Sell
1,474
-22
-1% -$6.23K 0.27% 69
2025
Q1
$466K Sell
1,496
-32
-2% -$9.45K 0.32% 55
2024
Q4
$398K Sell
1,528
-3
-0.2% -$890 0.26% 68
2024
Q3
$493K Buy
1,531
+35
+2% +$11.4K 0.35% 56
2024
Q2
$467K Buy
1,496
+73
+5% +$21.4K 0.36% 50
2024
Q1
$405K Sell
1,423
-19
-1% -$5.56K 0.34% 69
2023
Q4
$415K Sell
1,442
-61
-4% -$16.6K 0.34% 66
2023
Q3
$404K Buy
1,503
+9
+0.6% +$2.25K 0.38% 60
2023
Q2
$332K Buy
1,494
+53
+4% +$12.3K 0.3% 73
2023
Q1
$348K Sell
1,441
-225
-14% -$55.2K 0.37% 64
2022
Q4
$438K Buy
+1,666
New +$447K 0.53% 50

Other funds holding AMGN

Semus Wealth Partners's AMGN Position: Q1 2026 in Review

Semus Wealth Partners increased its Amgen (AMGN) stake by 0.62% in Q1 2026, buying an estimated $3.21K and bringing the position to 1,458 shares worth $513K. The position accounts for 0.29% of the portfolio, ranked #61.

Semus Wealth Partners first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Semus Wealth Partners held 1,458 shares of Amgen worth $513K as of Q1 2026.
  • Semus Wealth Partners bought 9 Amgen shares in Q1 2026, an estimated $3.21K.
  • Amgen made up 0.29% of Semus Wealth Partners's portfolio in Q1 2026, its #61 holding.
  • Semus Wealth Partners first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Semus Wealth Partners's 13F filing for Q1 2026, filed 24 Apr 2026.